AssayQuant Technologies Inc

Why not use the best substrate for your assays, designed for your enzyme? Our proprietary PhosphoSens Technology uses novel, fluorogenic sensors in enzyme recognition sequences that are carefully optimized for each enzyme to relay quantitative information on phosphorylation in real time with less effort. - Our direct, real-time, kinetic, enzyme activity assays yield better, more reliable data than other methods, enabling better decisions regarding target biology and generation of lead candidates to empower faster movement through the drug discovery process. - Whether used in high, moderate or low throughput modes, the resulting richer information from quantitative data allows you to...

Protein phosphatases,continuous (kinetic) assays,protein kinases,compound testing,ic50,kinact/ki,residence time,covalent inhibitors,enzyme inhibition,enzyme activation,fluorescence,assay development,phosphosens,peptide,kinase,phosphatase,phosphorylation,dephosphorylation,kinetics,enzymology,kinome profiling,kinase inhibitor,small molecule drug discovery,cro,dose respone,egfr,cdk,and tyrosine kinase

Assayquant technologies inc operates in the Biotechnology research industry.

Assayquant technologies inc's revenue is 11m - 100m

Assayquant technologies inc has 11 - 50 employees.